| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/23/2002 | DE10057754A1 New cyclic sulfonamido-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation |
| 05/23/2002 | DE10057443A1 Use of specific antibodies, or individual chains, for treating tumors and vascular occlusions, by inhibition of the gpIIb/IIIa receptor |
| 05/23/2002 | DE10055588A1 Konjugat, dessen Herstellung und Verwendung Conjugate, its preparation and use |
| 05/23/2002 | DE10054019A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments |
| 05/23/2002 | CA2763223A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 05/23/2002 | CA2460057A1 Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease |
| 05/23/2002 | CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 05/23/2002 | CA2429437A1 Imidazole derivatives, process for their preparation and their use |
| 05/23/2002 | CA2429342A1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | CA2429329A1 Bombesin receptor antagonists |
| 05/23/2002 | CA2429106A1 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| 05/23/2002 | CA2428863A1 Cysteine protease inhibitors |
| 05/23/2002 | CA2428844A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 05/23/2002 | CA2428787A1 Benzimidazole derivatives |
| 05/23/2002 | CA2428748A1 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 05/23/2002 | CA2428709A1 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | CA2428707A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | CA2428647A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 05/23/2002 | CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | CA2428519A1 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | CA2428350A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | CA2428249A1 Combination therapy for estrogen-dependent disorders |
| 05/23/2002 | CA2427656A1 Crf receptor antagonists and methods relating thereto |
| 05/23/2002 | CA2426521A1 Treatment of sexual dysfunction using bombesin antagonist |
| 05/23/2002 | CA2426089A1 Bombesin receptor antagonists |
| 05/23/2002 | CA2425117A1 Dibenzoxazepine alpha v integrin receptor antagonist |
| 05/22/2002 | EP1207201A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/22/2002 | EP1207198A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/22/2002 | EP1207158A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 05/22/2002 | EP1207157A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 05/22/2002 | EP1207156A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 05/22/2002 | EP1207155A1 Drug compositions exhibiting thrombopoietin agonism |
| 05/22/2002 | EP1206942A1 Water channel opener compositions and medicinal compositions for ophthalmic use |
| 05/22/2002 | EP1206941A1 Activity potentiators for chemotherapeutics, anticancer compositions and method for potentiating the activity of chemotherapeutics |
| 05/22/2002 | EP1206938A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)- piperdine derivatives |
| 05/22/2002 | EP1206934A1 Blockade of sodium channels by phenol derivatives |
| 05/22/2002 | EP1206911A1 Growth promoting compositions for mammals and method of promoting the growth of mammals by using the same |
| 05/22/2002 | EP1206581A2 Methods of identifying anti-viral agents |
| 05/22/2002 | EP1206569A2 Method of screening for triacyglycerol hydrolase inhibitors |
| 05/22/2002 | EP1206562A2 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 05/22/2002 | EP1206553A2 Isomerase proteins |
| 05/22/2002 | EP1206529A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 05/22/2002 | EP1206528A2 Chimeric dna/rna ribozymes containing propanediol |
| 05/22/2002 | EP1206527A1 Treatment of inflammatory or malignant disease using dnazymes |
| 05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
| 05/22/2002 | EP1206484A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/22/2002 | EP1206480A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 05/22/2002 | EP1206474A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 05/22/2002 | EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | EP1206472A1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent |
| 05/22/2002 | EP1206471A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 05/22/2002 | EP1206467A1 N-heterocyclic derivatives as nos inhibitors |
| 05/22/2002 | EP1206465A1 Fatty acid synthase inhibitors |
| 05/22/2002 | EP1206464A1 Fatty acid synthase inhibitors |
| 05/22/2002 | EP1206463A1 Fatty acid synthase inhibitors |
| 05/22/2002 | EP1206462A2 Heterocyclic compounds inhibiting angiogenesis |
| 05/22/2002 | EP1206458A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 05/22/2002 | EP1206457A1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 05/22/2002 | EP1206455A1 ALPHAvBETA3 INTEGRIN INHIBITORS |
| 05/22/2002 | EP1206451A1 Cyclopropylindole derivatives |
| 05/22/2002 | EP1206446A1 Carboxylic acid amides, their production and their use as drugs |
| 05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
| 05/22/2002 | EP1206436A2 Retinoids for the treatment of emphysema |
| 05/22/2002 | EP1206285A2 Drug-carrier complexes and methods of use thereof |
| 05/22/2002 | EP1206279A1 Method for treating tnf-receptor type-2-induced diseases |
| 05/22/2002 | EP1206265A1 Src kinase inhibitor compounds |
| 05/22/2002 | EP1206262A1 Npy antagonists: spiroisoquinolinone derivatives |
| 05/22/2002 | EP1206261A2 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
| 05/22/2002 | EP1206260A1 Src kinase inhibitor compounds |
| 05/22/2002 | EP1206242A1 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
| 05/22/2002 | EP1206234A2 Methods and compositions for modulating cell proliferation and cell death |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1152776B1 Biodegradable, injectable oligomer-polymer composition |
| 05/22/2002 | EP1147107A4 Novel angiogenesis inhibitors |
| 05/22/2002 | EP1089722B1 Matrix-type transdermal patch for steroid hormones |
| 05/22/2002 | EP1049487B1 Treatment of acute intermittent porphyria (aip) and other porphyric diseases |
| 05/22/2002 | EP1042334B1 Acyl phosph(on)ate inhibitors of beta-lactamase |
| 05/22/2002 | EP0902681B1 Inhibition of selectin binding |
| 05/22/2002 | EP0888349B1 Pyrrolopyrimidines and processes for their preparation |
| 05/22/2002 | EP0766676B1 Compounds for inhibiting phosphodiesterase iv |
| 05/22/2002 | EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
| 05/22/2002 | EP0563238B1 Imidazolyl-alkenoic acids |
| 05/22/2002 | EP0452364B1 Method for preparing water soluble polypeptides |
| 05/22/2002 | CN1350543A 14 beta-H-sterols, PHarmaceutical composiutions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments |
| 05/22/2002 | CN1350542A Xylo-LNA analogues |
| 05/22/2002 | CN1350537A Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | CN1350536A 氨基甲酰基四氢吡啶衍生物 Carbamoyl tetrahydropyridine derivative |
| 05/22/2002 | CN1350535A Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 05/22/2002 | CN1350533A New ECE inhibitors, their production and their use |
| 05/22/2002 | CN1350530A 酰胺衍生物 Amide derivatives |
| 05/22/2002 | CN1350528A 4,5,6,7-tetrahydroindazole derivatives as antitumor agents |
| 05/22/2002 | CN1350524A Quinoline derivatives as inhibitors of MEK enzymes |
| 05/22/2002 | CN1350523A Indoline derivatives as progesterohe antagonists |
| 05/22/2002 | CN1350465A Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetiques |
| 05/22/2002 | CN1350463A A Pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
| 05/22/2002 | CN1350458A Protease inhibitors |
| 05/22/2002 | CN1350454A Apomorphine and sildenafil composition |
| 05/22/2002 | CN1349989A 4-hydroxyl-piperidine derivative |